A study to compare the effectiveness of two different types of painkiller topical formulations

Prospective,open-label,randomized,parallel group,comparative clinical study of two topical formulations of diclofenac diethylamine in the treatment of acute painful musculoskeletal conditions.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/04/013316

Enrollment

140

Registered

2018-04-17

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients suffering from acute musculoskeletal painful conditions

Interventions

Intervention1: topical solution of diclofenac diethylamine (4.64%): this agent is used on patients satisfying the the inclusion criteria topically 4 times a day for 7 days and the pain relief will be

Eligibility

Inclusion criteria

Inclusion criteria: All adult patients with acute painful musculoskeletal pain

Exclusion criteria

Exclusion criteria: 1. All patients denying consent to participate in the trial 2. All patients with deep abrasions and lacerations around the area of affliction 3. Individuals with known adverse reaction to topical Diclofenac preparations.

Design outcomes

Primary

Measure	Time frame
Pain intensity difference (PID) from baseline (before starting treatment) during movement (of affected area) and at restTimepoint: Day 3 and 7	—

Secondary

Measure	Time frame
1.Requirement of oral analgesics 2. Side effectsTimepoint: Day 3 and 7	—

Countries

India

Contacts

Public ContactVivek mathew philip

Armed Forces Medical College

vivekphilip121@yahoo.com7507011166

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026